Cancer Indicators - Niagara County
2007-2009
| Indicator | Data Links | 3 Year Total | County Rate | NYS Rate | Sig.Dif. | NYS Rate exc NYC | Sig.Dif. | County Ranking Group |
|---|---|---|---|---|---|---|---|---|
| All cancers | ||||||||
| Crude incidence per 100,000 | (Table) (Trend) (Map) | 4,176 | 649.5 | 536.5 | Yes | 599.7 | Yes | 3rd |
| Age-adjusted incidence per 100,000 | (Table) (Trend) (Map) | 4,176 | 529.0 | 489.6 | Yes | 520.0 | No | 3rd |
| Crude mortality rate per 100,000 | (Table) (Trend) (Map) | 1,491 | 231.9 | 179.9 | Yes | 204.1 | Yes | 3rd |
| Age-adjusted mortality rate per 100,000 | (Table) (Trend) (Map) | 1,491 | 184.5 | 163.0 | Yes | 173.9 | No | 3rd |
| Lip, Oral Cavity, and Pharynx Cancer | ||||||||
| Crude incidence per 100,000 | (Table) (Trend) (Map) | 110 | 17.1 | 11.5 | Yes | 12.7 | Yes | 4th |
| Age-adjusted incidence per 100,000 | (Table) (Trend) (Map) | 110 | 13.5 | 10.4 | Yes | 10.8 | No | 4th |
| Crude mortality rate per 100,000 | (Table) (Trend) (Map) | 27 | 4.2 | 2.3 | Yes | 2.4 | Yes | 4th |
| Age-adjusted mortality rate per 100,000 | (Table) (Trend) (Map) | 27 | 3.2 | 2.1 | No | 2.0 | No | 4th |
| Colon and rectum cancer | ||||||||
| Crude incidence per 100,000 | (Table) (Trend) (Map) | 368 | 57.2 | 50.4 | Yes | 53.9 | No | 3rd |
| Age-adjusted incidence per 100,000 | (Table) (Trend) (Map) | 368 | 45.7 | 45.8 | No | 46.2 | No | 2nd |
| Crude mortality rate per 100,000 | (Table) (Trend) (Map) | 127 | 19.8 | 17.4 | No | 18.5 | No | 3rd |
| Age-adjusted mortality rate per 100,000 | (Table) (Trend) (Map) | 127 | 15.7 | 15.7 | No | 15.7 | No | 2nd |
| Lung and bronchus cancer | ||||||||
| Crude incidence per 100,000 | (Table) (Trend) (Map) | 619 | 96.3 | 69.8 | Yes | 83.9 | Yes | 3rd |
| Age-adjusted incidence per 100,000 | (Table) (Trend) (Map) | 619 | 77.6 | 63.8 | Yes | 72.2 | No | 2nd |
| Crude mortality rate per 100,000 | (Table) (Trend) (Map) | 462 | 71.9 | 46.9 | Yes | 57.2 | Yes | 4th |
| Age-adjusted mortality rate per 100,000 | (Table) (Trend) (Map) | 462 | 57.6 | 42.8 | Yes | 49.0 | Yes | 3rd |
| Female breast cancer | ||||||||
| Crude incidence per 100,000 | (Table) (Trend) (Map) | 612 | 184.9 | 147.1 | Yes | 164.9 | Yes | 4th |
| Age-adjusted incidence per 100,000 | (Table) (Trend) (Map) | 612 | 143.4 | 126.9 | Yes | 136.1 | No | 4th |
| Crude mortality rate per 100,000 | (Table) (Trend) (Map) | 111 | 33.5 | 26.7 | Yes | 28.8 | No | 4th |
| Age-adjusted mortality rate per 100,000 | (Table) (Trend) (Map) | 111 | 25.5 | 21.7 | No | 22.2 | No | 4th |
| Crude late stage incidence per 100,000 | (Table) (Trend) (Map) | 24 | 7.3 | 8.0 | No | 8.3 | No | 2nd |
| Age-adjusted late stage incidence per 100,000 | (Table) (Trend) (Map) | 24 | 5.8 | 6.8 | No | 6.8 | No | 2nd |
| Cervix uteri cancer | ||||||||
| Crude incidence per 100,000 | (Table) (Trend) (Map) | 25 | 7.6 | 8.9 | No | 7.9 | No | 2nd |
| Age-adjusted incidence per 100,000 | (Table) (Trend) (Map) | 25 | 6.7 | 8.3 | No | 7.4 | No | 2nd |
| Crude mortality rate per 100,000 | (Table) (Trend) (Map) | 3 | 0.9* | 2.7 | No | 2.2 | No | 1st |
| Age-adjusted mortality rate per 100,000 | (Table) (Trend) (Map) | 3 | 0.8* | 2.3 | No | 1.9 | No | 1st |
| Ovarian cancer | ||||||||
| Crude incidence per 100,000 | (Table) (Trend) (Map) | 54 | 16.3 | 15.2 | No | 16.5 | No | 3rd |
| Age-adjusted incidence per 100,000 | (Table) (Trend) (Map) | 54 | 13.4 | 12.9 | No | 13.4 | No | 3rd |
| Crude mortality rate per 100,000 | (Table) (Trend) (Map) | 31 | 9.4 | 9.6 | No | 11.0 | No | 2nd |
| Age-adjusted mortality rate per 100,000 | (Table) (Trend) (Map) | 31 | 7.1 | 7.8 | No | 8.5 | No | 2nd |
| Prostate cancer | ||||||||
| Crude incidence per 100,000 | (Table) (Trend) (Map) | 643 | 206.1 | 169.1 | Yes | 186.0 | Yes | 4th |
| Age-adjusted incidence per 100,000 | (Table) (Trend) (Map) | 643 | 177.0 | 166.9 | No | 171.2 | No | 4th |
| Crude mortality rate per 100,000 | (Table) (Trend) (Map) | 64 | 20.5 | 18.5 | No | 19.2 | No | 3rd |
| Age-adjusted mortality rate per 100,000 | (Table) (Trend) (Map) | 64 | 20.0 | 21.6 | No | 20.8 | No | 2nd |
| Crude late stage incidence per 100,000 | (Table) (Trend) (Map) | 15 | 4.8 | 6.7 | No | 6.6 | No | 2nd |
| Age-adjusted late stage incidence per 100,000 | (Table) (Trend) (Map) | 15 | 4.1 | 7.2 | Yes | 6.6 | No | 1st |
| Melanoma cancer mortality | ||||||||
| Crude mortality rate per 100,000 | (Table) (Trend) (Map) | 16 | 2.5 | 2.3 | No | 3.1 | No | 2nd |
| Age-adjusted mortality rate per 100,000 | (Table) (Trend) (Map) | 16 | 1.9 | 2.1 | No | 2.7 | No | 2nd |
| Age-adjusted % of women 18 years and older with pap smear in past 3 years (2008-2009) | (Table) (Map) | N/A | 87.6 | 82.7 | No | 82.6 | No | 1th |
| % of women 40 years and older with mammography screening in past 2 years (2008-2009) | (Table) (Map) | N/A | 82.0 | 79.7 | No | 81.9 | No | 1th |
N/A: Data not available
*: Fewer than 10 events in the numerator, therefore the rate is unstable
